FDA.reportPublic FDA data

Application 208347

Type
ANDA
Sponsor
LUPIN ATLANTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATEFOR SUSPENSION;ORALEQ 6MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-4188Oseltamivir PhosphateOseltamivir PhosphateA-S Medication SolutionsANDACurrent
50090-4188Oseltamivir PhosphateOseltamivir PhosphateA-S Medication SolutionsANDACurrent
68071-4733Oseltamivir PhosphateOseltamivir PhosphateNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4733Oseltamivir PhosphateOseltamivir PhosphateNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4733Oseltamivir PhosphateOseltamivir PhosphateNuCare Pharmaceuticals,Inc.ANDACurrent
68180-678Oseltamivir PhosphateOseltamivir PhosphateLupin Pharmaceuticals, Inc.ANDACurrent
68180-678Oseltamivir PhosphateOseltamivir PhosphateLupin Pharmaceuticals, Inc.ANDACurrent
68180-678Oseltamivir PhosphateOseltamivir PhosphateLupin Pharmaceuticals, Inc.ANDACurrent
68180-678Oseltamivir PhosphateOseltamivir PhosphateLupin Pharmaceuticals, Inc.ANDACurrent
68180-678Oseltamivir PhosphateOseltamivir PhosphateLupin Pharmaceuticals, InANDACurrent
71205-489Oseltamivir PhosphateOseltamivir PhosphateProficient Rx LPANDACurrent
71205-489Oseltamivir PhosphateOseltamivir PhosphateProficient Rx LPANDACurrent